Vanguard Group Inc Taysha Gene Therapies, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,894,127 shares of TSHA stock, worth $54.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,894,127
Previous 8,770,921 24.21%
Holding current value
$54.9 Million
Previous $12.2 Million 106.42%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$1.13 - $2.9 $2.4 Million - $6.16 Million
2,123,206 Added 24.21%
10,894,127 $25.2 Million
Q1 2025

May 09, 2025
SELL
$1.39 - $2.05 $188,821 - $278,478
-135,843 Reduced 1.53%
8,770,921 $12.2 Million
Q4 2024

Feb 11, 2025
BUY
$1.27 - $3.24 $814,457 - $2.08 Million
641,305 Added 7.76%
8,906,764 $15.4 Million
Q3 2024

Nov 13, 2024
BUY
$2.01 - $2.46 $2.21 Million - $2.7 Million
1,098,122 Added 15.32%
8,265,459 $16.6 Million
Q2 2024

Aug 13, 2024
BUY
$2.04 - $4.17 $2.55 Million - $5.21 Million
1,249,923 Added 21.12%
7,167,337 $16.1 Million
Q1 2024

May 10, 2024
SELL
$1.43 - $3.25 $397,758 - $903,997
-278,153 Reduced 4.49%
5,917,414 $17 Million
Q4 2023

Feb 14, 2024
BUY
$1.33 - $2.88 $1.15 Million - $2.5 Million
867,703 Added 16.29%
6,195,567 $11 Million
Q3 2023

Nov 14, 2023
BUY
$0.63 - $3.66 $2.36 Million - $13.7 Million
3,738,616 Added 235.24%
5,327,864 $16.8 Million
Q2 2023

Aug 14, 2023
BUY
$0.59 - $0.87 $3,427 - $5,054
5,810 Added 0.37%
1,589,248 $1.05 Million
Q1 2023

May 15, 2023
BUY
$0.65 - $2.3 $18,051 - $63,875
27,772 Added 1.79%
1,583,438 $1.27 Million
Q4 2022

Feb 10, 2023
BUY
$1.39 - $2.98 $673,960 - $1.44 Million
484,864 Added 45.28%
1,555,666 $3.52 Million
Q2 2022

Aug 12, 2022
BUY
$2.47 - $6.77 $144,835 - $396,979
58,638 Added 5.79%
1,070,802 $3.98 Million
Q1 2022

May 13, 2022
BUY
$5.22 - $11.86 $670,858 - $1.52 Million
128,517 Added 14.54%
1,012,164 $6.6 Million
Q4 2021

Feb 14, 2022
BUY
$11.43 - $19.2 $890,728 - $1.5 Million
77,929 Added 9.67%
883,647 $10.3 Million
Q3 2021

Nov 12, 2021
BUY
$15.82 - $21.57 $2.8 Million - $3.82 Million
177,074 Added 28.17%
805,718 $15 Million
Q2 2021

Aug 13, 2021
BUY
$19.29 - $26.38 $12.1 Million - $16.6 Million
628,644 New
628,644 $13.3 Million

Others Institutions Holding TSHA

# of Institutions
156
Shares Held
244M
Call Options Held
107K
Put Options Held
17K
View Full List

About Taysha Gene Therapies, Inc.

TSHA Quotes by TradingView
  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $244M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email